 Johannes von Alvensleben
Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventricular Dysfunction, Left | 8 | 2024 | 389 | 2.060 |
Why?
| | Electrocardiography | 8 | 2023 | 632 | 1.880 |
Why?
| | Defibrillators, Implantable | 5 | 2024 | 316 | 1.660 |
Why?
| | Heart Defects, Congenital | 8 | 2023 | 832 | 1.540 |
Why?
| | Tachycardia, Supraventricular | 3 | 2022 | 45 | 1.450 |
Why?
| | Arrhythmias, Cardiac | 5 | 2023 | 331 | 1.430 |
Why?
| | Catheter Ablation | 6 | 2023 | 349 | 1.410 |
Why?
| | Tachycardia, Ventricular | 6 | 2023 | 174 | 1.350 |
Why?
| | Pacemaker, Artificial | 2 | 2024 | 119 | 1.330 |
Why?
| | Prosthesis Implantation | 2 | 2024 | 153 | 0.970 |
Why?
| | Echocardiography, Transesophageal | 1 | 2024 | 101 | 0.870 |
Why?
| | Echocardiography, Three-Dimensional | 1 | 2024 | 52 | 0.870 |
Why?
| | Heart Conduction System | 2 | 2020 | 100 | 0.790 |
Why?
| | Ventricular Premature Complexes | 1 | 2022 | 36 | 0.770 |
Why?
| | Syncope | 2 | 2023 | 52 | 0.710 |
Why?
| | Heart Function Tests | 1 | 2019 | 61 | 0.650 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2019 | 236 | 0.630 |
Why?
| | Ventricular Function, Left | 5 | 2024 | 540 | 0.630 |
Why?
| | Tetralogy of Fallot | 4 | 2023 | 78 | 0.600 |
Why?
| | Diagnostic Imaging | 1 | 2021 | 339 | 0.590 |
Why?
| | Heart Atria | 2 | 2023 | 136 | 0.560 |
Why?
| | Anti-Arrhythmia Agents | 2 | 2021 | 115 | 0.550 |
Why?
| | Nadolol | 1 | 2016 | 5 | 0.540 |
Why?
| | Flecainide | 1 | 2016 | 7 | 0.540 |
Why?
| | Equipment Failure Analysis | 1 | 2017 | 132 | 0.530 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2017 | 87 | 0.520 |
Why?
| | Fontan Procedure | 3 | 2023 | 179 | 0.510 |
Why?
| | Heart Rate | 1 | 2020 | 831 | 0.510 |
Why?
| | Pulmonary Valve | 4 | 2023 | 98 | 0.470 |
Why?
| | Heart Septum | 1 | 2014 | 27 | 0.460 |
Why?
| | Punctures | 1 | 2014 | 40 | 0.460 |
Why?
| | Child | 24 | 2024 | 22037 | 0.460 |
Why?
| | Pediatrics | 2 | 2020 | 1123 | 0.460 |
Why?
| | Retrospective Studies | 19 | 2024 | 15628 | 0.440 |
Why?
| | Cardiac Surgical Procedures | 2 | 2022 | 531 | 0.440 |
Why?
| | Heart Transplantation | 3 | 2024 | 749 | 0.400 |
Why?
| | Death, Sudden, Cardiac | 5 | 2023 | 184 | 0.390 |
Why?
| | Cardiac Catheterization | 1 | 2014 | 528 | 0.350 |
Why?
| | Treatment Outcome | 11 | 2024 | 10821 | 0.350 |
Why?
| | Adolescent | 19 | 2024 | 21555 | 0.350 |
Why?
| | Myocardial Contraction | 3 | 2024 | 343 | 0.340 |
Why?
| | Predictive Value of Tests | 4 | 2024 | 2039 | 0.330 |
Why?
| | Atrioventricular Block | 2 | 2022 | 36 | 0.330 |
Why?
| | Heart Valve Prosthesis Implantation | 3 | 2023 | 182 | 0.320 |
Why?
| | Long QT Syndrome | 3 | 2019 | 70 | 0.310 |
Why?
| | Cardiomyopathy, Hypertrophic | 3 | 2019 | 142 | 0.300 |
Why?
| | Humans | 34 | 2024 | 137514 | 0.300 |
Why?
| | Postoperative Complications | 3 | 2020 | 2641 | 0.290 |
Why?
| | Aortic Valve Stenosis | 2 | 2022 | 229 | 0.280 |
Why?
| | Michigan | 3 | 2016 | 108 | 0.270 |
Why?
| | Hemodynamics | 3 | 2021 | 1114 | 0.270 |
Why?
| | Hypertension, Pulmonary | 1 | 2018 | 1903 | 0.250 |
Why?
| | Female | 22 | 2024 | 73162 | 0.250 |
Why?
| | Pulmonary Valve Insufficiency | 2 | 2023 | 43 | 0.230 |
Why?
| | Diastole | 2 | 2022 | 150 | 0.230 |
Why?
| | Fluoroscopy | 1 | 2024 | 162 | 0.220 |
Why?
| | Electrodes, Implanted | 1 | 2024 | 116 | 0.220 |
Why?
| | Male | 19 | 2024 | 67718 | 0.220 |
Why?
| | Allografts | 1 | 2024 | 148 | 0.210 |
Why?
| | Case-Control Studies | 4 | 2024 | 3546 | 0.200 |
Why?
| | Principal Component Analysis | 1 | 2023 | 197 | 0.200 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2023 | 148 | 0.200 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2022 | 43 | 0.190 |
Why?
| | Catheters | 1 | 2022 | 72 | 0.190 |
Why?
| | Pre-Excitation Syndromes | 1 | 2021 | 5 | 0.180 |
Why?
| | Accessory Atrioventricular Bundle | 1 | 2021 | 13 | 0.180 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2022 | 198 | 0.180 |
Why?
| | Bundle of His | 1 | 2021 | 18 | 0.180 |
Why?
| | Glycogen Storage Disease Type IIb | 1 | 2021 | 25 | 0.180 |
Why?
| | Truncus Arteriosus | 1 | 2020 | 5 | 0.180 |
Why?
| | Cardiac Electrophysiology | 1 | 2020 | 18 | 0.170 |
Why?
| | Electrophysiologic Techniques, Cardiac | 2 | 2018 | 82 | 0.170 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 1 | 2021 | 73 | 0.170 |
Why?
| | Fetal Heart | 1 | 2021 | 55 | 0.170 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2021 | 121 | 0.170 |
Why?
| | Dextrocardia | 1 | 2019 | 3 | 0.160 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 59 | 0.160 |
Why?
| | Transposition of Great Vessels | 1 | 2019 | 36 | 0.160 |
Why?
| | Aortic Diseases | 1 | 2020 | 117 | 0.160 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2019 | 42 | 0.160 |
Why?
| | Heart Septal Defects, Atrial | 1 | 2019 | 54 | 0.150 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 84 | 0.150 |
Why?
| | Ebstein Anomaly | 1 | 2018 | 6 | 0.150 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 423 | 0.150 |
Why?
| | Atrial Fibrillation | 1 | 2023 | 390 | 0.150 |
Why?
| | Software | 1 | 2023 | 670 | 0.140 |
Why?
| | Heart Ventricles | 2 | 2023 | 792 | 0.140 |
Why?
| | Infant, Newborn | 2 | 2021 | 6059 | 0.140 |
Why?
| | Young Adult | 10 | 2021 | 13243 | 0.140 |
Why?
| | Tachycardia, Reciprocating | 1 | 2017 | 6 | 0.140 |
Why?
| | Bradycardia | 1 | 2017 | 55 | 0.130 |
Why?
| | Atrial Flutter | 1 | 2017 | 36 | 0.130 |
Why?
| | Magnetic Resonance Imaging, Cine | 3 | 2023 | 193 | 0.130 |
Why?
| | Genetic Testing | 1 | 2019 | 453 | 0.130 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1486 | 0.120 |
Why?
| | Magnetic Resonance Imaging | 4 | 2023 | 3722 | 0.120 |
Why?
| | Fetal Diseases | 1 | 2017 | 172 | 0.120 |
Why?
| | Vascular Stiffness | 1 | 2020 | 492 | 0.120 |
Why?
| | Incidence | 3 | 2021 | 2792 | 0.120 |
Why?
| | Age of Onset | 1 | 2016 | 522 | 0.120 |
Why?
| | Cardiography, Impedance | 1 | 2013 | 8 | 0.100 |
Why?
| | Registries | 1 | 2021 | 2021 | 0.100 |
Why?
| | Risk Factors | 5 | 2024 | 10356 | 0.100 |
Why?
| | Blood Pressure | 1 | 2019 | 1776 | 0.100 |
Why?
| | Heart Arrest | 1 | 2016 | 339 | 0.100 |
Why?
| | Heart Diseases | 1 | 2014 | 359 | 0.090 |
Why?
| | Databases, Factual | 1 | 2016 | 1351 | 0.090 |
Why?
| | Mass Screening | 1 | 2019 | 1264 | 0.090 |
Why?
| | Time Factors | 4 | 2024 | 6817 | 0.080 |
Why?
| | Biomechanical Phenomena | 2 | 2024 | 768 | 0.080 |
Why?
| | Electrocardiography, Ambulatory | 2 | 2021 | 63 | 0.080 |
Why?
| | Adult | 8 | 2021 | 37821 | 0.070 |
Why?
| | Middle Aged | 4 | 2024 | 33355 | 0.070 |
Why?
| | Child, Preschool | 5 | 2024 | 11097 | 0.070 |
Why?
| | Infant | 2 | 2022 | 9467 | 0.070 |
Why?
| | Colorado | 1 | 2017 | 4521 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2021 | 5139 | 0.060 |
Why?
| | Aged | 1 | 2024 | 23798 | 0.060 |
Why?
| | Cohort Studies | 1 | 2014 | 5730 | 0.050 |
Why?
| | Echocardiography, Doppler | 1 | 2024 | 109 | 0.050 |
Why?
| | Area Under Curve | 1 | 2024 | 316 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2020 | 3708 | 0.050 |
Why?
| | Age Factors | 2 | 2024 | 3301 | 0.050 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2021 | 30 | 0.050 |
Why?
| | Fetal Monitoring | 1 | 2021 | 15 | 0.040 |
Why?
| | Esophagus | 1 | 2023 | 255 | 0.040 |
Why?
| | Swine | 1 | 2023 | 775 | 0.040 |
Why?
| | Diabetic Cardiomyopathies | 1 | 2020 | 36 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2021 | 401 | 0.040 |
Why?
| | Systole | 1 | 2020 | 191 | 0.040 |
Why?
| | Subcutaneous Tissue | 1 | 2019 | 24 | 0.040 |
Why?
| | Temperature | 1 | 2023 | 680 | 0.040 |
Why?
| | Heart Failure | 1 | 2013 | 2222 | 0.040 |
Why?
| | Mutation | 2 | 2021 | 3964 | 0.040 |
Why?
| | Aortic Valve | 1 | 2022 | 352 | 0.040 |
Why?
| | Autografts | 1 | 2019 | 45 | 0.040 |
Why?
| | Heart | 1 | 2023 | 660 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3292 | 0.040 |
Why?
| | Secondary Prevention | 1 | 2019 | 233 | 0.040 |
Why?
| | British Columbia | 1 | 2018 | 21 | 0.040 |
Why?
| | Pedigree | 1 | 2019 | 514 | 0.040 |
Why?
| | Myocardium | 1 | 2023 | 1004 | 0.040 |
Why?
| | Primary Prevention | 1 | 2019 | 197 | 0.040 |
Why?
| | Germany | 1 | 2018 | 121 | 0.030 |
Why?
| | Coronary Artery Disease | 1 | 2024 | 703 | 0.030 |
Why?
| | Gestational Age | 1 | 2021 | 903 | 0.030 |
Why?
| | Perioperative Period | 1 | 2017 | 56 | 0.030 |
Why?
| | Coronary Vessel Anomalies | 1 | 2016 | 34 | 0.030 |
Why?
| | Pregnancy | 2 | 2021 | 6745 | 0.030 |
Why?
| | Electric Stimulation | 1 | 2016 | 272 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 547 | 0.030 |
Why?
| | Calcium | 1 | 2021 | 1233 | 0.030 |
Why?
| | Magnetic Resonance Angiography | 1 | 2016 | 240 | 0.030 |
Why?
| | Odds Ratio | 1 | 2017 | 1063 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1460 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2719 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 621 | 0.030 |
Why?
| | Patient Selection | 1 | 2018 | 691 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1524 | 0.030 |
Why?
| | Survival Rate | 1 | 2018 | 1980 | 0.030 |
Why?
| | United States | 2 | 2021 | 14696 | 0.020 |
Why?
| | Logistic Models | 1 | 2017 | 2064 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 2870 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3205 | 0.020 |
Why?
| | Animals | 2 | 2023 | 37011 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1950 | 0.020 |
Why?
| | Risk Assessment | 1 | 2016 | 3439 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 7598 | 0.010 |
Why?
| | Mice | 1 | 2021 | 17843 | 0.010 |
Why?
|
|
von Alvensleben's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|